An Albuterol Inhaler is a prescription-based asthma inhaler which is typically used when there is an asthma attack. Albuterol can cause side effects and the amount of inhalations should not be administered more often than prescribed.

Who Uses An Albuterol Inhaler?

An Albuterol Inhaler is mainly used by patients with asthma or exercise-induced asthma, whose airways are obstructed when breathing (bronchospasm). It can also be used to treat patients with emphysema and chronic bronchitis when their symptoms are related to reversible airway obstruction.

Who Should Use An Albuterol Inhaler With Caution?

Patients with coronary heart diseases or cardiac rhythm disturbances (arrhythmias) should use an Albuterol Inhaler with caution. The combined effect of albuterol with other stimulant medications will affect the heart rate and blood pressure and may potentially cause chest pain in patients with underlying coronary heart disease.

Excessive use of albuterol inhalations will have adverse effects on the heart. Always remember to follow proper inhalation technique and the specific instructions that come with the drug packaging should be followed exactly.

An Albuterol Inhaler is a Metered-Dosed Inhaler (MDI) that typically comes either CFC (Chlorofluorocarbon) or HFA (Hydrofluoroalkane) propelled. CFC are the commonly used propellant in the early days of MDIs.

What Are The Different Types Of Albuterol Inhaler?

HFA are the more environmental-friendly propellant found in the newer models of MDI. An HFA-propelled Albuterol Inhaler may taste and feel different than a CFC-propelled one. You may feel the spray of an HFA-propelled inhaler softer.

CFC-propelled Albuterol Inhalers will be phasing out as they have been found to be harmful to the environment by contributing to depletion of the ozone layer above the Earth’s surface. Effectively after December 31st 2008, CFC-propelled inhalers will not be available in the United States.

Hence, CFC-propelled Albuterol Inhaler users are strongly urged to consult their health service provider to switch to HFA-propelled inhalers soonest as FDA (U.S. Food And Drug Administration) has approved the latter and manufacturers have increased the their production for adequate supply and purchase.